Predictive circulating biomarkers of the response to anti‐PD‐1 immunotherapy in advanced HER2 negative breast cancer

Predictive circulating biomarkers of the response to anti‐PD‐1 immunotherapy in advanced HER2 negative breast cancer

Abstract Background Immunotherapy shows promise for treating advanced breast cancer, but only a few patients could respond. Predictive biomarkers from peripheral blood are urgently needed. Methods We designed a comprehensive 42‐marker mass cytometry panel to profile the peripheral blood samples from...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuhan Wei, Hewei Ge, Yalong Qi, Cheng Zeng, Xiaoying Sun, Hongnan Mo, Fei Ma
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Series:	Clinical and Translational Medicine
Subjects:	breast cancer CyTOF immunotherapy PD‐1 peripheral blood mononuclear cell predictive biomarkers
Online Access:	https://doi.org/10.1002/ctm2.70255
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Activated platelets stimulate effector CD8+ T cells to enhance HNSCC immunotherapy efficacy
by: Zhennan Yuan, et al.
Published: (2025-05-01)

CyTOF as a suitable tool for stratification and monitoring of cancer patients
by: Barbara Seliger, et al.
Published: (2025-07-01)

Multiparametric analysis in the peripheral blood of Giant Cell Arteritis and Polymyalgia Rheumatica patients at the early phases of steroid treatment reveals changes in cell subpopulations and lipid mediators: a preliminary study
by: Dimitris Anastasios Palamidas, et al.
Published: (2025-06-01)

CyTOF reveals platelet subtype changes predicting the efficacy of combined immunotherapy and targeted therapy in liver cancer
by: Wenjing Wang, et al.
Published: (2025-05-01)

Identification of CD38high Monocyte as a Candidate Diagnostic Biomarker and Therapeutic Target for Sepsis
by: Ning Hua, et al.
Published: (2025-06-01)

Plasma testosterone concentration is correlated with circulating immune cell abundance in transgender young people on gender-affirming hormone treatment
by: Alice A. White, et al.
Published: (2025-07-01)

Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases
by: Daniela Michlmayr, et al.
Published: (2018-08-01)

Cytometry‐based single‐cell analysis of intact epithelial signaling reveals MAPK activation divergent from TNF‐α‐induced apoptosis in vivo
by: Alan J Simmons, et al.
Published: (2015-10-01)

Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia
by: Veronika Dill, et al.
Published: (2024-12-01)

Deciphering the preeclampsia-specific immune microenvironment and the role of pro-inflammatory macrophages at the maternal–fetal interface
by: Haiyi Fei, et al.
Published: (2025-03-01)

Phenotypic changes in immune cells induced by granulocyte and monocyte adsorptive apheresis in patients with severe COVID‐19: An ex vivo study
by: Ryo Hisamune, et al.
Published: (2024-01-01)

Parameter optimization for stable clustering using FlowSOM: a case study from CyTOF
by: Weiyang Tao, et al.
Published: (2024-10-01)

Immune profiling identifies CD161+CD127+CD8+ T cells as a predictive biomarker for Anti-PD-L1 therapy response in the SCLC-I subtype
by: Jingjing Qu, et al.
Published: (2025-07-01)

An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn’s disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytes
by: Andrew Yung Fong Li Yim, et al.
Published: (2025-08-01)

Understanding the long-term interplay of SARS-CoV-2 immune and inflammatory responses with proteases in COVID-19 recovery: a longitudinal study
by: Natalia Ćwilichowska-Puślecka, et al.
Published: (2025-06-01)

The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical cancer: new perspectives on cervical cancer immunotherapy
by: Jin Li, et al.
Published: (2024-12-01)

Structural and temporal dynamics analysis of PD-1/PD-L1 immunotherapy in hepatocellular carcinoma: History, research hotspots, and emerging trends
by: Talaiti Tuergan, et al.
Published: (2025-12-01)

Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer
by: Yuhan Wei, et al.
Published: (2025-01-01)

An updated review of immunotherapy in esophageal cancer: PD-L1 footprint
by: Juan Yao, et al.
Published: (2024-05-01)

Utilizing Nanoparticles to Overcome Anti-PD-1/PD-L1 Immunotherapy Resistance in Non-Small Cell Lung cancer: A Potential Strategy
by: Ge Y, et al.
Published: (2025-02-01)

Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
by: Yizhou Zhang, et al.
Published: (2024-12-01)

Theoretical investigation on PD-L1-In-1 for cancer immunotherapy via density functional theory
by: Bijay Sijapati Magar, et al.
Published: (2025-08-01)

Current perspectives on tertiary lymphoid structures and PD-1/PD-L1 signaling pathway in the immunotherapy of hepatocellular carcinoma
by: Hao-Dong QIAO, et al.
Published: (2023-10-01)

Targeting PD-1 post-translational modifications for improving cancer immunotherapy
by: Jie Shi, et al.
Published: (2025-06-01)

Progress of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of triple-negative breast cancer
by: Hongshu Li, et al.
Published: (2025-04-01)

Metabolism of tryptophan in non-small lung cancer patients with different effect of PD-1 / PD-L1 inhibitors immunotherapy
by: E. Yu. Zlatnik, et al.
Published: (2022-06-01)

Dissecting the link between PD-1/PD-L1-based immunotherapy and cancer pain: mechanisms, research implications, and artificial intelligence perspectives
by: Marco Cascella, et al.
Published: (2024-12-01)

Comprehensive characterization of PD-L1 expression and immunotherapy-related genomic biomarkers in early- versus advanced-stage non-small cell lung cancer
by: Yujie Chen, et al.
Published: (2025-05-01)

Relative expression orderings based prediction of treatment response to Anti-PD-1 immunotherapy in advanced melanoma
by: Yaru Gao, et al.
Published: (2025-03-01)

Comparison of treatment outcome between first‐line combination immunotherapy (anti‐PD‐L1 or anti‐PD1) with or without chemotherapy and chemotherapy alone in advanced non‐small cell lung cancer patients in tertiary care hospital
by: Danainut Naratornsirakul, et al.
Published: (2024-07-01)

Cryoablation synergizes with anti-PD-1 immunotherapy induces an effective abscopal effect in murine model of cervical cancer
by: Xiaoming Yang, et al.
Published: (2025-01-01)

Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01)

TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives
by: Zhuohong Yan, et al.
Published: (2025-05-01)

Developing a PK-PD model for propofol in exhaled air and the BIS following fospropofol disodium in beagles
by: Xiaoxiao Li, et al.
Published: (2025-02-01)

USP5-Mediated PD-L1 deubiquitination regulates immunotherapy efficacy in melanoma
by: Jiaheng Xie, et al.
Published: (2025-07-01)

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
by: David Dora, et al.
Published: (2023-12-01)

The Potential of PD-1 and PD-L1 as Prognostic and Predictive Biomarkers in Colorectal Adenocarcinoma Based on TILs Grading
by: Nur Rahmah Rasyid, et al.
Published: (2024-11-01)

Novel cell therapy with ex vivo cultured peripheral blood mononuclear cells significantly impacts angiogenesis in the murine ischemic limb model
by: Satomi Furukawa, et al.
Published: (2024-06-01)

Platelet‐to‐Neutrophil Ratio: A Novel Prognostic Indicator for Anti‐PD‐1‐Based Therapy in Relapsed/Refractory Hodgkin Lymphoma and Solid Tumors
by: Yuting Pan, et al.
Published: (2025-06-01)

Single-cell analysis reveals potential therapeutic markers of peripheral blood mononuclear cells from bladder cancer patients
by: Xingning Mao, et al.
Published: (2025-05-01)